|
Report Date : |
02.01.2013 |
IDENTIFICATION DETAILS
|
Name : |
AMRI INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
713, 7TH Floor, Exim Link Building, Mulund-Goregaon Link Road,
Opposite Indira Container Yard, Nahur (West), Mumbai-400078, Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2010 |
|
|
|
|
Date of
Incorporation : |
07.04.2007 |
|
|
|
|
Com. Reg. No.: |
11-169746 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs. 948.803 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U7499MH2007FTC169746 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMA30116C |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAGCA2555H |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Marketing of active pharmaceutical ingredients and
other pharmaceutical intermediates. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B (29) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 2200000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having moderate track record. The management
of the company has failed to file its financials with the government
departments since 2010. However, as per previous year’s, there appears decline in the
company’s income and increase in its accumulated losses. Business is found to be active. Payments terms are unknown. The company can be considered for business dealings with some
caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
India is developing into an open-market economy, yet traces of
its past autarkic policies remain. Economic liberalization, including
industrial deregulation, privatization of state-owned enterprises, and reduced
controls on foreign trade and investment, began in the early 1990s and has
served to accelerate the country's growth, which has averaged more than 7% per
year since 1997. India's diverse economy encompasses traditional village
farming, modern agriculture, handicrafts, a wide range of modern industries,
and a multitude of services. Slightly more than half of the work force is in
agriculture, but services are the major source of economic growth, accounting
for more than half of India's output, with only one-third of its labor force.
India has capitalized on its large educated English-speaking population to become
a major exporter of information technology services and software workers. In
2010, the Indian economy rebounded robustly from the global financial crisis -
in large part because of strong domestic demand - and growth exceeded 8%
year-on-year in real terms. However, India's economic growth in 2011 slowed
because of persistently high inflation and interest rates and little progress
on economic reforms. High international crude prices have exacerbated the
government's fuel subsidy expenditures contributing to a higher fiscal deficit,
and a worsening current account deficit. Little economic reform took place in
2011 largely due to corruption scandals that have slowed legislative work.
India's medium-term growth outlook is positive due to a young population and
corresponding low dependency ratio, healthy savings and investment rates, and
increasing integration into the global economy. India has many long-term
challenges that it has not yet fully addressed, including widespread poverty,
inadequate physical and social infrastructure, limited non-agricultural
employment opportunities, scarce access to quality basic and higher education,
and accommodating rural-to-urban migration.
|
Source
: CIA |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION DECLINED BY
Management non co-operative
LOCATIONS
|
Registered Office : |
713, 7TH Floor, Exim Link Building, Mulund-Goregaon Link Road,
Opposite Indira Container Yard, Nahur (West), Mumbai-400078, Maharashtra,
India |
|
Tel. No.: |
Not Available |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
Unit 2, Plot No.G-1/1, G-1/2, MIDC Area, Waluj, Aurangabad-431136,
Maharashtra, India |
|
Tel No.: |
91-240-2554006 |
DIRECTORS
AS ON 13.06.2011
|
Name : |
Mr. Michael Paul Williams |
|
Designation : |
Director |
|
Address : |
14, |
|
Date of Birth/Age : |
10.04.1958 |
|
Date of Appointment : |
17.01.2008 |
|
DIN No.: |
02153759 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U74999MH2007FTC169746 |
AMRI
INDIA PRIVATE LIMITED |
Director |
07/04/2007 |
07/04/2007 |
Active |
NO |
|
2 |
U73200AP2005PTC045178 |
ALBANY
MOLECULAR RESEARCH HYDERABAD RESEARCH CENTRE PRIVATE LIMITED |
Director |
30/09/2008 |
28/12/2007 |
Active |
NO |
|
3 |
U24110MH2003PTC139025 |
FINEKEM
LABORATORIES PRIVATE LIMITED |
Director |
17/01/2008 |
17/01/2008 |
Active |
NO |
|
Name : |
Mr. Rajesh Shenoy |
|
Designation : |
Director |
|
Address : |
8-2-120/110/1/6, 2nd Floor, Jrresi Dence, Nandi Nagar Road-14,
Banhara Hills, Hyderabad-500034, Andhra Pradesh, India |
|
Date of Birth/Age : |
26.11.1962 |
|
Date of Appointment : |
18.05.2009 |
|
Date of Cessation : |
16.11.2011 |
|
DIN No.: |
01176175 |
|
|
|
|
Name : |
Mr. Sivakumar Sivasubramanian |
|
Designation : |
Director |
|
Address : |
#108, 4th Main Road, NGEF Layout, Sanjay Nagar,
Bangalore-560094, Karnataka, India |
|
Date of Birth/Age : |
23.04.1965 |
|
Date of Appointment : |
18.05.2009 |
|
Date of Cessation : |
01.03.2012 |
|
DIN No.: |
02548220 |
|
|
|
|
Name : |
Mr. Subramanyam Maddala
|
|
Designation : |
Additional Director |
|
Address : |
No.2B, Malavika Apartments, 3rd Main Road, Gandhi Nagar,
Adyar Chennai-600020, Tamilnadu, India |
|
Date of Birth/Age : |
26.11.1962 |
|
Date of Appointment : |
16.11.2011 |
|
DIN No.: |
05108930 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U73200AP2005PTC045178 |
ALBANY
MOLECULAR RESEARCH HYDERABAD RESEARCH CENTRE PRIVATE LIMITED |
Additional
director |
16/11/2011 |
16/11/2011 |
Active |
NO |
|
2 |
U24110MH2003PTC139025 |
FINEKEM
LABORATORIES PRIVATE LIMITED |
Additional
director |
16/11/2011 |
16/11/2011 |
Active |
NO |
|
3 |
U74999MH2007FTC169746 |
AMRI
INDIA PRIVATE LIMITED |
Additional
director |
16/11/2011 |
16/11/2011 |
Active |
NO |
|
Name : |
Mr. Lori Marie Henderson
|
|
Designation : |
Director |
|
Address : |
8, Oak Hill Road, Wayland Ma-017782904 |
|
Date of Birth/Age : |
02.12.1961 |
|
Date of Appointment : |
26.09.2011 |
|
DIN No.: |
03620416 |
Other Directorship:
|
S.No. |
CIN/LLPIN |
Name
of the Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date
of appointment at current designation |
Original
date of appointment |
Company/
LLP Status |
Defaulting
status |
|
1 |
U24110MH2003PTC139025 |
FINEKEM
LABORATORIES PRIVATE LIMITED |
Director |
16/09/2011 |
16/09/2011 |
Active |
NO |
|
2 |
U74999MH2007FTC169746 |
AMRI
INDIA PRIVATE LIMITED |
Director |
26/09/2011 |
26/09/2011 |
Active |
NO |
|
3 |
U73200AP2005PTC045178 |
ALBANY
MOLECULAR RESEARCH HYDERABAD RESEARCH CENTRE PRIVATE LIMITED |
Director |
27/09/2011 |
27/09/2011 |
Active |
NO |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 13.06.2011
|
Names of Shareholders |
No. of Shares |
|
Albany Molecular Research Mauritius Private Limited, Mauritius |
105349759 |
|
Michael Paul Williams |
1 |
|
TOTAL
|
105349760 |
AS ON 21.09.2011
|
Names of Allottees |
No. of Shares |
|
Albany Molecular Research Mauritius Private Limited, Mauritius |
1573250 |
|
TOTAL
|
1573250 |
AS ON 13.06.2011
|
Equity Shares
Break Up |
Percentage of
Holding |
|
Foreign holdings( Foreign institutional investor(s),
Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s)
or Overseas Corporate bodies or Others |
100.00 |
|
TOTAL |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Marketing of active pharmaceutical ingredients and
other pharmaceutical intermediates. |
PRODUCTION STATUS (AS ON : 31.03.2010)
|
Particulars |
Unit |
Installed
Capacity |
Actual
Production |
|
Atenolol |
Kgs. |
72000 |
40759 |
|
Frusomide |
Kgs. |
72000 |
46367 |
|
Metformin HCL |
Kgs. |
360000 |
137566 |
Note:
1. In terms of Press No.4 (1994 series) dated 25 October 1994 issued by the
Department of Industrial Development Ministry of Industry Government of India and
Notification No. S.O. 137 (E) dated 1st March 1999 issued by the
Government of India industrial licensing has been abolished in respect of bulk
drugs and formulations.
2. The installed capacity is as certified by the Management and not verified
by the Auditors this being a technical matter.
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|
|
|
|
Bankers : |
Not Available |
|
|
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
B S R And Company Chartered Accountant |
|
Address : |
8-2-618/2, Reliance Humsafar, 4th Floor, Road No.11,
Banjara Hills, Hyderabad-500034, Andhra Pradesh, India |
|
Tel. No.: |
91-40-30465000 |
|
Fax No.: |
91-40-30465299 |
|
PAN No.: |
AAIFB4734C |
|
|
|
|
Holding Company : |
Albany Molecular Research Mauritius Private Limited, Mauritius |
|
|
|
|
Ultimate Holding Company : |
Albany Molecular Research Inc |
|
|
|
|
Fellow Subsidiary : |
Albany Molecular Research Hyderabad Research Centre Private Limited |
|
|
|
|
Wholly Owned Subsidiaries : |
Finekem Laboratories Private Limited CIN No.: - U24110MH2003PTC139025 |
CAPITAL STRUCTURE
AFTER ON
13.06.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
125000000 |
Equity Shares |
Rs.10/- each |
Rs. 1250.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
105349760 |
Equity Shares |
Rs.10/- each |
Rs. 1053.498
Millions |
|
|
|
|
|
AS ON 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
125000000 |
Equity Shares |
Rs.10/- each |
Rs. 1250.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
94880260 |
Equity Shares |
Rs.10/- each |
Rs. 948.803
Millions |
|
|
|
|
|
Note:
Of the above 94880259 share are held by the
holding company Albany Molecular Research Mauritius Private Limited, Mauritius and 1 share
is held by its nominee.
AS ON 13.06.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
125000000 |
Equity Shares |
Rs.10/- each |
Rs. 1250.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital : Rs. 1161.163
Millions
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
948.803 |
948.803 |
446.260 |
|
|
2] Share Application Money |
82.580 |
0.000 |
303.170 |
|
|
3] Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
(472.492) |
(340.467) |
(118.388) |
|
|
NETWORTH |
558.891 |
608.336 |
631.042 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
0.000 |
0.000 |
0.000 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
558.891 |
608.336 |
631.042 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
281.071 |
311.980 |
393.092 |
|
|
Capital work-in-progress |
11.960 |
17.826 |
9.555 |
|
|
|
|
|
|
|
|
INVESTMENT |
30.545 |
30.545 |
30.545 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
35.592
|
66.027 |
54.411 |
|
|
Sundry Debtors |
29.184
|
30.137 |
50.262 |
|
|
Cash & Bank Balances |
36.921
|
43.422 |
43.702 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
205.934
|
187.029 |
111.596 |
|
Total
Current Assets |
307.631
|
326.615 |
259.971 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
62.789
|
65.814 |
50.404 |
|
|
Other Current Liabilities |
7.803
|
8.187 |
8.347 |
|
|
Provisions |
1.724
|
4.629 |
3.370 |
|
Total
Current Liabilities |
72.316
|
78.630 |
62.121 |
|
|
Net Current Assets |
235.315
|
247.985 |
197.850 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
558.891 |
608.336 |
631.042 |
|
PROFIT & LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
|
|
|
|
|
|
|
GROSS INCOME |
145.166 |
207.984 |
153.958 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
(97.544) |
(99.160) |
(163.119) |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
34.481 |
117.160 |
(45.126) |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
(132.025) |
(216.320) |
(117.993) |
|
|
|
|
|
|
|
|
|
Less |
TAX |
0.000 |
5.758 |
0.395 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
(132.025) |
(222.078) |
(118.388) |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
(340.466) |
(118.388) |
0.000 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
(472.491) |
(340.466) |
(118.388) |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
82.563 |
102.846 |
76.430 |
|
|
TOTAL EARNINGS |
82.563 |
102.846 |
76.430 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
23.519 |
89.180 |
60.890 |
|
|
|
Stores & Spares |
0.000 |
0.045 |
0.000 |
|
|
|
Capital Goods |
0.000 |
5.165 |
0.589 |
|
|
TOTAL IMPORTS |
23.519 |
94.390 |
61.479 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
(1.39) |
(4.02) |
(2.94) |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
Return on Total Assets (PBT/Total Assets} |
(%) |
(22.43)
|
(33.87) |
(18.07) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
(0.24)
|
(0.36) |
(0.19) |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.13
|
0.13 |
0.10 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
4.25
|
4.15 |
4.18 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
Yes |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
No |
|
24] |
Banking facility details |
No |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
No |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth
of Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External
Agency Rating, if available |
No |
NOTE
Registered office has been shifted from B, 3rd Floor, Hitech
Plaza, Plot No.46/228, Mahakali Caves Road, Andheri (East), Mumbai-400093, Maharashtra,
India to the present address w.e.f.31.12.2010.
BACKGROUND
Subject was incorporated on 7th April 2007 as a private
limited company. The company is a wholly owned subsidiary of Albany Molecular
Research Mauritius Private Limited. The ultimate parent company is Albany
Molecular Research Inc. During the year 2007-08, the company acquired the
business of manufacture of active pharmaceutical ingredients and other
pharmaceutical intermediates from Ariane Orgachem Private Limited in Aurangabad
and from Ferico Laboratories Limited in Navi Mumbai.
The company’s principal activities comprise manufacture and marketing of
active pharmaceutical ingredients and other pharmaceutical intermediates.
BUSINESS OUTLOOK
The economic slowdown
in European countries still pose a challenge in terms of corporate earnings and
the company has taken necessary steps to meet the challenges ahead. Due to
ongoing economic crisis in western countries, there could be impact on revenue
as considerable portion comes from supplies to non-regulated European markets.
Despite these influences, their commitment to invest in their facilities (own
and subsidiary), improvements in their products and human resources will
continue for next 2-3 years.
Company has
discontinued one of its product, Metformin since July 2009 onwards as the
margins were negative due to higher input prices and cost of disposing
effluents generated from its facility. Hence, the revenue for the current year
is lower compared to the previous year.
FIXED ASSETS
·
Goodwill
·
Freehold Land
·
Building
·
Leasehold Land
·
Plant and Machinery
·
Computers
·
Furniture and Fixtures
·
Office Equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record exists
to suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 54.83 |
|
|
1 |
Rs. 89.22 |
|
Euro |
1 |
Rs. 72.48 |
INFORMATION DETAILS
|
Report Prepared
by : |
DPT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
3 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
3 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
-- |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
4 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
29 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.